Indivior (NASDAQ:INDV) Shares Gap Down to $16.12

Indivior PLC (NASDAQ:INDV) gapped down before the market opened on Monday . The stock had previously closed at $16.12, but opened at $15.41. Indivior shares last traded at $15.53, with a volume of 95,809 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum assumed coverage on shares of Indivior in a research note on Wednesday, April 3rd. They set a “buy” rating and a $37.00 price objective on the stock.

Indivior Stock Down 3.0 %

The company has a current ratio of 0.92, a quick ratio of 0.74 and a debt-to-equity ratio of 23.50. The stock has a market capitalization of $2.11 billion, a P/E ratio of 1,527.00 and a beta of 0.69. The stock’s 50 day simple moving average is $17.18 and its 200 day simple moving average is $18.09.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Indivior had a return on equity of 842.72% and a net margin of 0.44%. The business had revenue of $284.00 million during the quarter, compared to the consensus estimate of $300.00 million. As a group, research analysts predict that Indivior PLC will post 2 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of INDV. Scopia Capital Management LP bought a new position in shares of Indivior in the 3rd quarter worth about $191,743,000. Vanguard Group Inc. lifted its position in shares of Indivior by 1.6% in the 3rd quarter. Vanguard Group Inc. now owns 5,846,354 shares of the company’s stock worth $134,875,000 after buying an additional 90,673 shares during the last quarter. Norges Bank bought a new position in shares of Indivior in the 4th quarter worth about $36,011,000. UBS Group AG lifted its position in shares of Indivior by 71.9% in the 4th quarter. UBS Group AG now owns 826,130 shares of the company’s stock worth $12,615,000 after buying an additional 345,556 shares during the last quarter. Finally, Renaissance Group LLC lifted its position in shares of Indivior by 6.1% in the 4th quarter. Renaissance Group LLC now owns 103,023 shares of the company’s stock worth $1,573,000 after buying an additional 5,896 shares during the last quarter. 60.33% of the stock is currently owned by institutional investors.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.